Alginates: Existing and potential biotechnological and medical applications

RSC Polymer Chemistry Series

Volumn , Issue , 2011, Pages 186-209

  Draget, Kurt I ^a   SkjåK Braek, Gudmund ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874916734     PISSN: 20440790     EISSN: 20440804     Source Type: Book Series    
DOI: None     Document Type: Article

References (88)

1. A. Haug, Composition and Properties of Alginates, Thesis, Norwegian Institute of Technology, Trondheim, 1964.
2. A. Haug, B. Larsen and O. Smidsrød, A study of the constitution of alginic acid by partial hydrolysis, Acta Chem. Scand., 1966, 20, 183-190.
3. A. Haug and B. Larsen, A study on the constitution of alginic acid by partial acid hydrolysis, Proc. Int. Seaweed Symp., 1966, 5, 271-277.
4. A. Haug, B. Larsen and O. Smidsrød, Studies on the sequence of uronic acid residues in alginic acid, Acta Chem. Scand., 1967a, 21, 691-704.
5. A. Haug and O. Smidsrød, Fractionation of alginates by precipitation with calcium and magnesium ions, Acta Chem. Scand., 1965, 19, 1221-1226.
6. T. J. Painter, O. Smidsrød and A. Haug, A computer study of the changes in composition-distribution occurring during random depolymerisation of a binary linear heteropolysachharide, Acta Chem. Scand., 1968, 22, 1637-1648.
7. B. Larsen, O. Smidsrød, T. J. Painter and A. Haug, Calculation of the nearest-neighbour frequencies in fragments of alginate from the yields of free monomers after partial hydrolysis, Acta Chem. Scand., 1970, 24, 726-728.
8. O. Smidsrød and S. G.Whittington,Monte Carlo investigation of chemical inhomogeneity in copolymers, Macromolecules, 1969, 2, 42-44.
9. G. Skjak-Bræk, B. Larsen and H. Grasdalen, Monomer sequence and acetylation pattern in some bacterial alginates, Carbohydr. Res., 1986, 154, 239-250.
10. E. D. T. Atkins, W. Mackie and E. E. Smolko, Crystalline structures of alginic acids, Nature, 1970, 225, 626-628.
11. O. Smidsrød, R. M. Glover and S. G. Whittington, The relative extension of alginates having different chemical composition, Carbohydr. Res., 1973, 27, 107-118.
12. H. Grasdalen, B. Larsen and O. Smidsrød, 13C-NMR studies of alginate, Carbohydr. Res., 1977, 56, C11-C15.
13. O. Smidsrød, Solution properties of alginate, Carbohydr. Res., 1970, 13, 359-372.
14. M. Indergaard and G. Skjak-Bræk, Characteristics of alginate from Laminaria digitata cultivated in a high phosphate environment, Hydrobiologia, 1987, 151/152, 541-549.
15. S. Valla, H. Ertesvåg and G. Skjak-Bræk, Genetics and biosynthesis of alginates, Carbohydr. Eur., 1996, 14, 14-18.
16. O. Smidsrød and A. Haug, Dependence upon uronic acid composition of some ion-exchange properties of alginates, Acta Chem. Scand., 1968, 22, 1989-1997.
17. A. Haug and O. Smidsrød, Selectivity of some anionic polymers for divalent metal ions, Acta Chem. Scand., 1970, 24, 843-854.
18. O. Smidsrød, Some Physical Properties of Alginates in Solution and in the Gel State, Thesis, Norwegian Institute of Technology, Trondheim, 1973.
19. O. Smidsrød, Molecular basis for some physical properties of alginates in the gel state, J. Chem. Soc. Farad. Trans, 1974, 57, 263-274.
20. G. T. Grant, E. R. Morris, D. A. Rees, P. J. C. Smith and D. Thom, Biological interactions between polysaccharides and divalent cations: The egg-box model, FEBS letters, 1973, 32, 195-198.
21. W. Mackie, S. Perez, R. Rizzo, F. Taravel and M. Vignon, Aspects of the conformation of polyguluronate in the solid state and in solution, Int. J. Biol. Macromol., 1983, 5, 329-341.
22. C. A. Steginsky, J. M. Beale, H. G. Floss and R. M. Mayer, Structural determination of alginic acid and the effects of calcium binding as determined by high-field n.m.r., Carbohydr. Res., 1992, 225, 11-26.
23. B. T. Stokke, K. I. Draget, Y. Yuguchi, H. Urakawa and K. Kajiwara, Small angle X-ray scattering and rheological characterization of alginate gels. 1 Ca-alginate gels, Macromolecules, 2000, 33, 1853-1863.
24. K. I. Draget, E. Onsøyen, T. Fjæreide, M. K. Simensen and O. Smidsrød, Use of G-block polysaccharides', Intl. Pat. Appl. #PCT/NO97/00176, 1997.
25. O. Smidsrød and G. Skjak-Bræk, Alginate as immobilization matrix for cells, Trends in Biotechnology, 1990, 8, 71-78.
26. K. I. Draget, K. Østgaard and O. Smidsrød, Homogeneous alginate gels; a technical approach, Carbohydr. Polym., 1991, 14, 159-178.
27. G. Skjak-Bræk, H. Grasdalen and O. Smidsrød, Inhomogeneous polysaccharide ionic gels, Carbohydr. Polym., 1989, 10, 31-54.
28. A. Mikkelsen and A. Elgsæter, Density distribution of calcium-induced alginate gels, Biopolymers, 1995, 36, 17-41.
29. A. Martinsen, G. Skjak-Bræk and O. Smidsrød, Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads, Biotechnol. Bioeng., 1989, 33, 79-89.
30. K. I. Draget, G. Skjak-Bræk and O. Smidsrød, Alginic acid gels: The effect of alginate chemical composition and molecular weight, Carbohydr. Polym., 1994, 25, 31-38.
31. P. Soon-Shiong, M. Otterlei, G. Skjak-Bræk, O. Smidsrød, R. Heintz, R. P. Lanza and T. Espevik, An immunologic basis for the fibrotic reaction to implanted microcapsules, Transplant Proc., 1991, 23, 758-759.
32. P. Soon-Shiong, E. Feldman, R. Nelson, R. Heints, Q. Yao, T. Yao, N. Zheng, G. Merideth, G. Skjak-Bræk, T. Espevik, O. Smidsrød and P. Sandford, Long-term reversal of diabetes by the injection of immunoprotected islets, Proc. Natl. Acad. Sci., 1993, 90, 5843-5847.
33. B. T. Stokke, O. Smidsrød, F. Zanetti, W. Strand and G. Skjak-Bræk, Distribution of uronate residues in alginate chains in relation to gelling properties 2:Enrichment of b-D-mannuronic acid and depletion of a-Lguluronic acid in the sol fraction, Carbohydr. Polym., 1993, 21, 39-46.
34. T. Espevik and G. Skjak-Bræk, Application of alginate gels in biotechnology and biomedicine, Carbohydr. Eur., 1996, 14, 19-25.
35. H. Ertesvåg, B. Doseth, B. Larsen, G. Skjak-Bræk and S. Valla, Cloning and Expression of an Azotobacter vinelandii Mannuronan C-5-epimerase, Gene. J. Bacteriol, 1994, 176, 2846-2853.
36. H. Ertesvåg, H. K. Høidal, I. K. Hals, A. Rian, B. Doseth, S. Valla, A family of modular type mannuronan C-5-epimerase genes controls alginate structure in Azotobacter vinelandii. Mol. Microbiol. 1995, 16, 719-731.
37. H. Ertesvåg, H. K. Høidal, G. Skjak-Bræk and S. Valla, The Azotobacter vinelandii mannuronan C-5-epimerase AlgE1 consists of two separate catalytic domains, J. Biol. Chem., 1998, 273, 30927-30932.
38. H. K. Høidal, H. Ertesvåg, G. Skjak-Bræk, B. T. Stokke and S. Valla, The recombinant Azotobacter vinelandii mannuronan C-5-Epimerase AlgE4 epimerizes alginate by a nonrandom attack mechanism, J. Biol. Chem., 1999, 274, 12316-12322.
39. H. H. Tønnesen and J. Karlsen, Alginate in drug delivery systems, Drug development and industrial pharmacy, 2002, 28, 621-630.
40. M. Stadler and H. Viernstein, Optimization of a formulation containing viable lactic acid bacteria, Int. J. Pharmaceutics, 2003, 256, 117-122.
41. X. Liu, D. W. Chen, L. P. Xie and R. Q. Zhang, Oral colon-specific drug delivery for bee venom peptide; development of a coated calcium alginate gel beads entrapped liposome, J. Contr. Rel., 2003, 93, 293-300.
42. S. Y. Lyu, Y. J. Kwon, H. J. Joo and W. B. Park, Preparation of alginate/ chitosan microcapsules and enteric coated granules of mistletoe lectin, Arch. Pharm. Res., 2004, 118-126.
43. N. Acosta, I. Aranaz, C. Peniche and A. Heras, Tramadol release from a delivery system based on alginate-chitosan microcapsules, Macromol. Biosci., 2003, 3, 546-551.
44. L. M. Prisant, B. Bottini, J. T. Dipiro and A. A. Carr, Novel drug-delivery systems for hypertension, Am. J. Med., 1992, 93(Suppl. 2A), S45-S55.
45. L. M. Prisant and W. J. Elliot, Drug delivery systems for treatment of hypertension, Clinical Pharmacokinetics, 2003, 42, 931-940.
46. Anon, Council adapts American Dental Association specification no 18 (alginate impression material), J. Am. Dent. Ass., 1968, 77, 1354.
47. D. L. Wood, Dental alginate for taking impressions of the nose prior to rhinoplasty, Plastic and Reconstructive Surgery, 1997, 99, 2609-2670.
48. N. A. Stotts, M. J. Salazar, D. WipkeTevis and E. McAdoo, Accuracy of alginate molds for measuring wound volumes when prepared and stored under varying conditions, Wounds-A Compendium of Clinical Research and Practice, 1996, 8, 158-164.
49. S. Locke, S. Smith, B. Szeliski-Scott and E. D. Lemaire, A clear polycarbonate fase mask for the treatment of hypertrophic scars, J. Prostetics and Orthotiscs, 1991, 3, 182-190.
50. K. G. Mandel, B. P. Daggy, D. A. Brodie and H. I. Jacoby, Alginate-raft formulations in the treatment of heartburn and acid reflux, Alimentary Pharmacology & Therapeutics, 2000, 14, 669-690.
51. S. Chatfield, A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo treatment of gastro-oesophageal reflux disease, Current Medical Research and Opinion, 1999, 15, 152-159.
52. J. A. J. M. Taminiau, Gastro-oesophageal reflux in children, Scand. J. Gastroenterology, 1997, 32(Suppl. 223), 18-20.
53. S. W. Lindow, P. Regnell, J. Sykes and S. Little, An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance (R)) in the treatment of heartburn during pregnancy, Int. J. Clin. Pract., 2003, 57, 175-179.
54. J. D. Lalau, R. Bresson, P. Charpentier, V. Coliche, S. Erlher, G. H. Van, G. Magalon, J. Martini, Y. Moreau, S. Pradines, F. Rigal, J. L. Wermeau and J. L. Richards, Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions, Diabetes & Metabolism, 2002, 28, 223-229.
55. A. A. Marghoob, N. N. Artman and D. M. Siegel, Calcium alginate dressings with second intention healing of surgical wounds: Our experience, Wounds-A Compendium of Clinical Research and Practice, 1997, 9, 50-55.
56. A. B. G. Lansdown, Calcium: A potent central regulator in wound healing in the skin, Wound Repair and Regeneration, 2002, 10, 271-285.
57. A. Thomas, K. G. Harding and K. Moore, Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-alpha, Biomaterials, 2000, 21, 1797-1802.
58. Y. Nagawa, T. Murai, C. Hasegawa, M. Hirata, T. Tsuchiya, T. Yagami and Y. Haishima, Endotoxin contamination in wound dressings made of natural biomaterials, J. Biomed. Mat. Res. Part B-Appl. Biomat., 2003, 66B, 347-355.
59. Y. Suzuki, M. Tanihara, Y. Nishimura, K. Suzuki, Y. Yamawaki, H. Kudo, Y. Kakimaru and Y. Shimizu, In vivo evaluation of a novel alinate dressing, J. Biomed. Mat. Res., 1999, 48, 522-527.
60. L. H. Wang, E. Khor, A. Wee and L. Y. Lim, Chitosan-alginate PEC membrane as a wound dressing: Assessment of incisional wound healing, J. Biomed. Mat. Res., 2002, 63, 610-618.
61. B. K. Mann, Biologic gels in tissue engineering, Clinics in Plastic Surgery, 2003, 30, 601-609.
62. J. L. Drury and D. J. Mooney, Hydrogels for tissue engineering: Scaffold design variables and applications, Biomaterials, 2003, 24, 4337-4351.
63. W. M. Ku htreiber, R. P. Lanz, W. L. Chick, (Eds), Part III: Applications of cell encapsulated systems. In Cell Encapsulation Technology and Therapeutics, Birkha user, Boston, 1999, pp. 217-379.
64. P. Soon-Shiong, R. E. Heintz, N. Merideth, Q. X. Yao, Z. Yao, T. Zheng, M. Murphy, M. K. Moloney, M. Schmehl, M. Harris, R. Mendez and P. A. Sandford, Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation, The Lancet, 1994, 343, 950-951.
65. G. Orive, R. M. Hernandez, A. R. Gascon, R. Calafiore, T. M. S. Chang, P. de Vos, G. Hortelano, D. Hunkeler, I. Lacik and J. L. Pedraz, History challenges and perspectives of cell microencapsulation, Trends in Biotechnology, 2004, 22, 87-92.
66. S. Moe, K. I. Draget, G. Skjak-Bræk, O. Smidsrød, in Alginates, (Ed.) A. Stephen, Food Polysaccharides, Marcel Dekker, New York, 1995, pp. 245-287.
67. C. K. Rha, Chitosan as biomaterial, In Biotechnology in the Marine Sciences, (Eds) R. R. Colwell, E. R. Pariser, A. J. Sinskey, Wiley, New York, 1984, pp. 177-189.
68. O. Gå serød, O. Smidsrød and G. Skjak-Bræk, Microcapsules of alginatechitosan-I. A quantitative study of the interaction between alginate and chitosan, Biomaterials, 1998, 19, 1815-1825.
69. F. Lim and A. M. Sun, Microencapsulated islets as bioartificial endocrine pancreas, Science, 1980, 210, 908-910.
70. B. Thu, P. Bruheim, T. Espevik, O. Smidsrød and G. Skjak-Bræk, Alginate polycation microcapsules. I. Interaction between alginate and polycation, Biomaterials, 1996, 17, 1031-1040.
71. I. A. Veliky and R. E. Williams, The production of ethanol by Saccharomyces cerevisiae immobilized in polycation stabilized calcium alginate gels, Biotechnol. Lett., 1981, 33, 275-280.
72. H. Tanaka, H. Kurosawa, E. Kokufuta and I. A. Veliky, Preparation of immobilized glucoamylase using Ca-alginate gel coated with partially quaternized poly(ethyleneimine), Biotechnol. Bioeng., 1984, 26, 1393-1394.
73. H. Tanaka, M. Matsumura and I. A. Veliky, Diffusion characteristics of substrates in Ca-alginate gel beads, Biotechnol. Bioeng., 1984, 26, 53-58.
74. B. Kulseng, B. Thu, T. Espevik and G. Skjak-Bræk, Alginate polylysine capsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane, Cell Transplant., 1997, 6, 387-394.
75. O. Gå serød, A. Sannes and G. Skjak-Bræk, Microcapsules of alginatechitosan. II. A study of capsule stability and permeability, Biomaterials, 1999, 20, 773-783.
76. B. L. Strand, L. Ryan, P. In't Veld, B. Kulseng, A. M. Rokstad, G. Skjak-Bræk and T. Espevik, Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines, Cell Transplant., 2001, 10, 263-275.
77. M. Otterlei, A. Sundan, G. Skjak-Bræk, L. Ryan, O. Smidsrød and T. Espevik, Similar mechanisms of action of defined polysaccharides and liposacccharides: Characterization of binding and tumor necrosis factor alpha induction, Infect. Immun., 1993, 61, 1917-1926.
78. G. Berntzen, T. Flo, A. Medvedev, L. Kilaas, G. Skjak-Bræk, A. Sundan and T. Espevik, The tumor necrosis factor-inducing potency of lipopolysaccharide and uronic acid polymers is increased when they are covalently linked to particles, Clin. Diagn. Lab. Immunol., 1998, 5, 355-361.
79. G. Skjak-Bræk, T. Flo, Ø. Halaas, T. Espevik, Immune stimulating properties of di-equatorially b(1-4) linked poly-uronides. In Bioactive Carbohydrate Polymers, Kluwer Academic Publishers, Dordracht (NL), 2000. pp. 85-93.
80. Ø. Halaas, W. M. Olsen, O. P. Veiby, D. Løvhaug, G. Skjak-Bræk, R. Vik and T. Espevik, Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro, Scand. J. Immunol., 1997, 46, 358-365.
81. J. Skjermo, T. Defoort, M. Dehasque, T. Espevik, Y. Olsen, G. Skjak-Bræk, P. Sorgeloos and O. Vadstein, Immonustimulation of juvenile turbot (Scophthalmus maximus L.) using an alginate with high mannuronic acid content administrated via the live food organism Artemia, Fish Shellfish Immunol., 1995, 5, 531-534.
82. M. Otterlei, Ø. K. Stgaard, G. Skjak-Bræk, O. Smidsrød, P. Soon-Shiong and T. Espevik, Induction of cytokine production from human monocytes stimulated with alginate, J. Immunother., 1991, 10, 286-291.
83. T. Espevik, M. Otterlei, G. Skjak-Bræk, L. Ryan, S. D. Wright and A. Sundan, The involvement of CD14 in stimulation of cytokine production by uronic acid polymers, Eur. J. Immunol., 1993, 23, 255-261.
84. B. Weidemann, H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusomoto, H. D. Flad and A. J. Ulmer, Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid-A partial structures, Infect. Immun., 1994, 62, 4709-4715.
85. T. Kusunoki, E. Hailman, T. S.-C. Juan, H. S. Lichenstein and S. D. Wright, Moleculesfrom Staphylococcus aureus that bind CD14 and stimulate innate immune-responses, J. Exp. Med., 1995, 182, 1673-1682.
86. M. Soell, E. Lett, F. Holveck, M. Scholler, D. Wachsmann and J. Klein, Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan-binding protein inhibits TNF-alpha release, J. Immunol., 1995, 154, 851-860.
87. M. Otterlei, K. M. Vå rum, L. Ryan and T. Espevik, Characterization of binding and TNF-a-inducing ability of chitosans on monocytes: The involvement of CD14, Vaccine, 1994, 12, 825-832.
88. J. Pugin, D. Haumann, A. Tomasz, V. V. Kravchenko, M. P. Glauser, P. S. Tobias and R. J. Ulevich, CD14 is a pattern-recognition receptor, Immunity, 1994, 1, 509-516.